HSP90 inhibitors enhance differentiation and MITF (microphthalmia transcription factor) activity in osteoclast progenitors.
about
Molecular stress-inducing compounds increase osteoclast formation in a heat shock factor 1 protein-dependent mannerNatural compounds' activity against cancer stem-like or fast-cycling melanoma cells.Berberine Sulfate Attenuates Osteoclast Differentiation through RANKL Induced NF-κB and NFAT Pathways.Andrographolide Inhibits Ovariectomy-Induced Bone Loss via the Suppression of RANKL Signaling Pathways.Bajijiasu Abrogates Osteoclast Differentiation via the Suppression of RANKL Signaling Pathways through NF-κB and NFAT.Organ-specific efficacy of HSP90 inhibitor in multiple-organ metastasis model of chemorefractory small cell lung cancer.Protein kinase C inhibitor, GF109203X attenuates osteoclastogenesis, bone resorption and RANKL-induced NF-κB and NFAT activity.Clarithromycin decreases rhinovirus replication and cytokine production in nasal epithelial cells from subjects with bronchial asthma: effects on IL-6, IL-8 and IL-33.Eriodictyol Inhibits RANKL-Induced Osteoclast Formation and Function Via Inhibition of NFATc1 Activity.Luteoloside prevents lipopolysaccharide-induced osteolysis and suppresses RANKL-induced osteoclastogenesis through attenuating RANKL signaling cascades.Increased rhinovirus replication in nasal mucosa cells in allergic subjects is associated with increased ICAM-1 levels and endosomal acidification and is inhibited by L-carbocisteine.Melphalan modifies the bone microenvironment by enhancing osteoclast formation.miR-211 and MITF modulation by Bcl-2 protein in melanoma cells.
P2860
Q33676779-8564FBEC-7FB2-4324-903F-6DB0F8D22C12Q35111429-7CB1ADE7-BF35-4839-989B-2F02349235B4Q36324625-9B728B93-416F-45ED-8AD6-01E850BE10A6Q36324729-32353734-6643-45A1-A0F8-894309F74741Q37631691-76C65F7C-AEB5-4DC7-8713-24F4ECBA61EDQ38834735-CC3B3193-157F-4410-B603-1AB9B6C58686Q38943284-392EE80A-2F13-439F-827D-D0436EE3AEC6Q40061725-8A8E788A-3669-4BA7-8B06-492ECCD45BB6Q40120415-4302C7DE-AD58-4ED6-AA25-D63DD4D48C41Q40145765-F24F5E36-CE8E-4187-8C22-BB10E790C2B5Q40412413-E4DC661E-3597-41D2-B9EE-B9E0D2D81222Q42366597-64C8724C-FD77-4920-A6EB-388EEEEDCB07Q53266571-1CB5FC2E-2E63-4D24-AE49-1673C2FCD93D
P2860
HSP90 inhibitors enhance differentiation and MITF (microphthalmia transcription factor) activity in osteoclast progenitors.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
HSP90 inhibitors enhance diffe ...... ity in osteoclast progenitors.
@en
HSP90 inhibitors enhance differentiation and MITF
@nl
type
label
HSP90 inhibitors enhance diffe ...... ity in osteoclast progenitors.
@en
HSP90 inhibitors enhance differentiation and MITF
@nl
prefLabel
HSP90 inhibitors enhance diffe ...... ity in osteoclast progenitors.
@en
HSP90 inhibitors enhance differentiation and MITF
@nl
P2093
P2860
P50
P356
P1433
P1476
HSP90 inhibitors enhance diffe ...... vity in osteoclast progenitors
@en
P2093
A Gabrielle J van der Kraan
Julian M W Quinn
Preetinder P Singh
Ryan C C Chai
P2860
P304
P356
10.1042/BJ20121626
P407
P577
2013-04-01T00:00:00Z